Inventor · disambiguated record
David Edwin Thurston
Also filed as: THURSTON DAVID · THURSTON DAVID E · THURSTON DAVID EDWIN
20 granted patents·11 pending applications·1,880 citations·filing 1999–2022
97Inventor score
Top patents by PatentIndex Score
31 records- 0198US7265105B2PyrrolobenzodiazepinesSPIROGEN LTD·Filed 2006·Granted Sep 4, 2007·175 cites·3 claims
- 0298US7067511B2PyrrolobenzodiazepinesSPIROGEN LTD·Filed 2001·Granted Jun 27, 2006·209 cites·5 claims
- 0397US7244724B2PyrrolobenzodiazepinesSPIROGEN LTD·Filed 2005·Granted Jul 17, 2007·95 cites·14 claims
- 0497US7049311B1PyrrolbenzodiazepinesSPIROGEN LTD·Filed 1999·Granted May 23, 2006·272 cites·50 claims
- 0597US6909006B1Cyclopropylindole derivativesSPIROGEN LTD·Filed 2000·Granted Jun 21, 2005·99 cites·10 claims
- 0697US6562806B1PyrrolobenzodiazepinesSPIROGEN LTD·Filed 1999·Granted May 13, 2003·160 cites·25 claims
- 0796US9376440B2Pyrrolobenzodiazepines as antiproliferative agentsMEDIMMUNE LTD·Filed 2013·Granted Jun 28, 2016·37 cites·20 claims
- 0896US8637664B2Alkyl 4- [4- (5-oxo-2,3,5, 11a-tetrahydo-5H-pyrrolo [2, 1-c] [1,4] benzodiazepine-8-yloxy)-butyrylamino]-1H-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative diseaseHOWARD PHILIP WILSON·Filed 2006·Granted Jan 28, 2014·67 cites·7 claims
- 0996US7704924B2Library of compounds comprising pyrrolobenzodiazepine moietiesSPIROGEN LTD·Filed 2003·Granted Apr 27, 2010·113 cites·15 claims
- 1096US7528126B2PyrrolobenzodiazepinesSPIROGEN LTD·Filed 2005·Granted May 5, 2009·204 cites·9 claims
- 1196US7407951B2PyrrolobenzodiazepinesSPIROGEN LTD·Filed 2003·Granted Aug 5, 2008·155 cites·7 claims
- 1295US6608192B1Collections of compoundsSPIROGEN LTD·Filed 1999·Granted Aug 19, 2003·145 cites·12 claims
- 1393US6747144B1Collections of compoundsSPIROGEN LTD·Filed 1999·Granted Jun 8, 2004·117 cites·3 claims
- 1491US9321774B2PyrrolobenzodiazepinesMEDIMMUNE LTD·Filed 2013·Granted Apr 26, 2016·28 cites·20 claims
- 1580US10975074B2Anti-liferative agents comprising substituted benzo[e]pyrido[1,2-a][1,4]diazepinesFEMTOGENIX LTD·Filed 2019·Granted Apr 13, 2021·1 cites·30 claims
- 1675US10975072B2Substituted 6a,7,8,9,10,12-hexahydrobenzo[e]pyrido[1,2-a][1,4]diazepines as anti-proliferative agentsFEMTOGENIX LTD·Filed 2018·Granted Apr 13, 2021·1 cites·20 claims
- 1771US9999625B2Pyrrolobenzodiazepine compoundsFEMTOGENIX LTD·Filed 2015·Granted Jun 19, 2018·2 cites·20 claims
- 1865US11912700B2Anti-proliferative agents comprising substituted benzo[e]pyrido[1,2-a][1,4]diazepinesPHEON THERAPEUTICS LTD·Filed 2021·Granted Feb 27, 2024·0 cites·17 claims
- 1964US2024002379A1Asymmetric conjugate compoundsPHEON THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2063US2024109916A1Cytotoxic agentsPHEON THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2160US2018339985A1Pdd compoundsFEMTOGENIX LTD·Filed 2018·Application pending·0 cites
- 2255US2008039448A1PyrrolobenzodiazepinesUS GOV HEALTH & HUMAN SERV·Filed 2006·Application pending·0 cites
- 2355US2023302142A1Cytotoxic AgentsFEMTOGENIX LTD·Filed 2021·Application pending·0 cites
- 2454US2019144443A1Asymmetric conjugate compoundsFEMTOGENIX LTD·Filed 2018·Application pending·0 cites
- 2552US2004198722A1Collections of compoundsSPIROGEN LTD·Filed 2004·Application pending·0 cites
- 2649US2003195196A1PyrrolobenzodiazepinesSPIROGEN LTD·Filed 2003·Application pending·0 cites
- 2749US2022098191A1G-a crosslinking cytotoxic agentsFEMOGENIX LTD·Filed 2020·Application pending·0 cites
- 2848US11466032B2Cytotoxic agentsFEMTOGENIX LTD·Filed 2018·Granted Oct 11, 2022·0 cites·18 claims
- 2943US2021371413A1Polycyclic amides as cytotoxic agentsFEMTOGENIX LTD·Filed 2019·Application pending·0 cites
- 3034US10399970B2Pyrridinobenzodiazepine and benzopyrridodiazecine compoundsFEMTOGENIX LTD·Filed 2016·Granted Sep 3, 2019·0 cites·19 claims
- 3131US2020216432A1Sulfonamide derivatives as stat3 inhibitors for the treatment of proliferative diseasesKING S COLLEGE LONDON·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Edwin Thurston files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →